|
1
|
Moslemi D, Nokhandani AM, Otaghsaraei MT,
Moghadamnia Y, Kazemi S and Moghadamnia AA: Management of
chemo/radiation-induced oral mucositis in patients with head and
neck cancer: A review of the current literature. Radiother Oncol.
120:13–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Trotti A, Bellm LA, Epstein JB, Frame D,
Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L and Zilberberg MD:
Mucositis incidence, severity and associated outcomes in patients
with head and neck cancer receiving radiotherapy with or without
chemotherapy: A systematic literature review. Radiother Oncol.
66:253–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harada K, Ferdous T, Horinaga D, Uchida K,
Mano T, Mishima K, Park S, Hanazawa H, Takahashi S, Okita A, et al:
Efficacy of elemental diet on prevention for
chemoradiotherapy-induced oral mucositis in patients with oral
squamous cell carcinoma. Support Care Cancer. 24:953–959. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cooper JS, Pajak TF, Forastiere AA, Jacobs
J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et
al: Postoperative concurrent radiotherapy and chemotherapy for
high-risk squamous-cell carcinoma of the head and neck. N Engl J
Med. 350:1937–1944. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elliott EA, Wright JR, Swann RS,
Nguyen-Tân F, Takita C, Bucci MK, Garden AS, Kim H, Hug EB, Ryu J,
et al: Phase III trial of an emulsion containing trolamine for the
prevention of radiation dermatitis in patients with advanced
squamous cell carcinoma of the head and neck: Results of radiation
therapy oncology group trial 99–13. J Clin Oncol. 24:2092–2097.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giro C, Berger B, Bölke E, Ciernik IF,
Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG,
et al: High rate of severe radiation dermatitis during radiation
therapy with concurrent cetuximab in head and neck cancer: Results
of a survey in EORTC institutes. Radiother Oncol. 90:166–171. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mead GM: Management of oral mucositis
associated with cancer chemotherapy. Lancet. 359:815–816. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vélez I, Tamara LA and Mintz S: Management
of oral mucositis induced by chemotherapy and radiotherapy: An
update. Quintessence Int. 35:129–136. 2004.PubMed/NCBI
|
|
9
|
Lalla RV, Bowen J, Barasch A, Elting L,
Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O,
Peterson DE, et al: MASCC/ISOO clinical practice guidelines for the
management of mucositis secondary to cancer therapy. Cancer.
120:1453–1461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stokman MA, Spijkervet FK, Boezen HM,
Schouten JP, Roodenburg JL and de Vries EG: Preventive intervention
possibilities in radiotherapy- and chemotherapy-induced oral
mucositis: Results of meta-analyses. J Dent Res. 85:690–700. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keefe DM, Schubert MM, Elting LS, Sonis
ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB,
Hutchins RD and Peterson DE: Mucositis Study Section of the
Multinational Association of Supportive Care in Cancer and the
International Society for Oral Oncology: Updated clinical practice
guidelines for the prevention and treatment of mucositis. Cancer.
109:820–831. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Henke M, Alfonsi M, Foa P, Giralt J,
Bardet E, Cerezo L, Salzwimmer M, Lizambri R, Emmerson L, Chen MG
and Berger D: Palifermin decreases severe oral mucositis of
patients undergoing postoperative radiochemotherapy for head and
neck cancer: A randomized, placebo-controlled trial. J Clin Oncol.
29:2815–2820. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu JL, Xia R, Sun ZH, Sun L, Min X, Liu C,
Zhang H and Zhu YM: Effects of honey use on the management of
radio/chemotherapy-induced mucositis: A meta-analysis of randomized
controlled trials. Int J Oral Maxillofac Surg. 45:1618–1625. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wischmeyer PE: Clinical applications of
L-glutamine: Past, present, and future. Nutr Clin Pract.
18:377–385. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Neu J, DeMarco V and Li N: Glutamine:
Clinical applications and mechanisms of action. Curr Opin Clin Nutr
Metab Care. 5:69–75. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skubitz KM and Anderson PM: Oral glutamine
to prevent chemotherapy induced stomatitis: A pilot study. J Lab
Clin Med. 127:223–228. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silverman S Jr: Diagnosis and management
of oral mucositis. J Support Oncol. 5 2 Suppl 1:S13–S21. 2007.
|
|
18
|
Savarese DM, Savy G, Vahdat L, Wischmeyer
PE and Corey B: Prevention of chemotherapy and radiation toxicity
with glutamine. Cancer Treat Rev. 29:501–513. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi K, Lee SS, Oh SJ, Lim SY, Lim SY,
Jeon WK, Oh TY and Kim JW: The effect of oral glutamine on
5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by
intestinal permeability test. Clin Nutr. 26:57–62. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leung HW and Chan AL: Glutamine in
alleviation of radiation-induced severe oral mucositis: A
meta-analysis. Nutr Cancer. 68:734–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang EY, Leung SW, Wang CJ, Chen HC, Sun
LM, Fang FM, Yeh SA, Hsu HC and Hsiung CY: Oral glutamine to
alleviate radiation-induced oral mucositis: A pilot randomized
trial. Int J Radiat Oncol Biol Phys. 46:535–539. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cerchietti LC, Navigante AH, Lutteral MA,
Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G,
Sheinker B and Uchima P: Double-blinded, placebo-controlled trial
on intravenous L-alanyl-L-glutamine in the incidence of oral
mucositis following chemoradiotherapy in patients with head
and-neck cancer. Int J Radiat Oncol Biol Phys. 65:1330–1337. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chattopadhyay S, Saha A, Azam M, Mukherjee
A and Sur PK: Role of oral glutamine in alleviation and prevention
of radiation-induced oral mucositis: A prospective randomized
study. South Asian J Cancer. 3:8–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsujimoto T, Yamamoto Y, Wasa M, Takenaka
Y, Nakahara S, Takagi T, Tsugane M, Hayashi N, Maeda K, Inohara H,
et al: L-glutamine decreases the severity of mucositis induced by
chemoradiotherapy in patients with locally advanced head and neck
cancer: A double-blind, randomized, placebo-controlled trial. Oncol
Rep. 33:33–39. 2015.PubMed/NCBI
|
|
25
|
Vidal-Casariego A, Calleja-Fernández A,
Ballesteros-Pomar MD and Cano-Rodríguez I: Efficacy of glutamine in
the prevention of oral mucositis and acute radiation induced
esophagitis: A retrospective study. Nutr Cancer. 65:424–429. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yarom N, Ariyawardana A, Hovan A, Barasch
A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J and Lalla RV:
Mucositis Study Group of the Multinational Association of
Supportive Care in Cancer/International Society of Oral Oncology
(MASCC/ISOO): Systematic review of natural agents for the
management of oral mucositis in cancer patients. Support Care
Cancer. 21:3209–3221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jebb SA, Osborne RJ, Maughan TS, Mohideen
N, Mack P, Mort D, Shelley MD and Elia M: 5-fluorouracil and
folinic acid induced mucositis: No effect of oral glutamine
supplementation. Br J Cancer. 70:732–735. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anderson PM, Schroeder G and Skubitz KM:
Oral glutamine reduces the duration and severity of stomatitis
after cytotoxic cancer chemotherapy. Cancer. 83:1433–1439. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okuno SH, Woodhouse CO, Loprinzi CL, Sloan
JA, LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert LP,
Tirona MR, et al: Phase III controlled evaluation of glutamine for
decreasing stomatitis in patients receiving fluorouracil
(5-FU)-based chemotherapy. Am J Clin Oncol. 22:258–261. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ward E, Smith M, Henderson M, Reid U,
Lewis I, Kinsey S, Allgar V, Bowers D and Picton SV: The effect of
high-dose enteral glutamine on the incidence and severity of
mucositis in paediatric oncology patients. Eur J Clin Nutr.
63:134–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rubio IT, Cao Y, Hutchins LF, Westbrook KC
and Klimberg VS: Effect of glutamine on methotrexate efficacy and
toxicity. Ann Surg. 227:772–778; 778–780. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cockerham MB, Weinberger BB and Lerchie
SB: Oral glutamine for the prevention of oral mucositis associated
with high-dose paclitaxel and melphalan for autologous bone marrow
transplantation. Ann Pharmacother. 34:300–303. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peterson DE, Jones JB and Petit RG II:
Randomized, placebo-controlled trial of Saforis for prevention and
treatment of oral mucositis in breast cancer patients receiving
anthracycline-based chemotherapy. Cancer. 109:322–331. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Imai T, Matsuura K, Asada Y, Sagai S,
Katagiri K, Ishida E, Saito D, Sadayasu R, Wada H and Saijo S:
Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in
head and neck cancer patients treated with concurrent
chemoradiotherapy. Jpn J Clin Oncol. 44:422–427. 2014. View Article : Google Scholar : PubMed/NCBI
|
